NCT07254468

Brief Summary

This study aims to investigate the effects of Cardiovascular Autonomic Neuropathy (CAN) on Acute Kidney Injury (AKI) and clinical outcomes in patients undergoing isolated Coronary Artery Bypass Graft (CABG) surgery requiring extracorporeal circulation(ECC). Preoperative data including demographics, comorbidities, kidney function tests, hemodynamic parameters, and baseline regional cerebral oxygen saturation (rSO2) will be recorded. Intraoperative data will include hemodynamics, urine output, blood gases, cardiopulmonary bypass and aortic cross-clamp times, cardioplegia details, number of coronary anastomoses, and rSO2 changes at defined time points. Postoperatively, kidney function, neurological status, mechanical ventilation duration, inotropic drug use, transfusion requirements, complications, ICU and hospital length of stay, and mortality will be evaluated. Acute Kidney Injury will be classified according to KDIGO criteria. The primary objective is to analyze the effect of CAN on AKI. Secondary objectives include assessing the impact of CAN on other clinical outcomes and exploring the relationship between CAN and intraoperative cerebral oxygen changes. This study has been approved by the Acıbadem University and Acıbadem Healthcare Institutions Medical Research Ethics Committee (ATADEK) and will be conducted following ethical principles and good clinical practice.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
912

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 4, 2021

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 10, 2025

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

November 18, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 28, 2025

Completed
Last Updated

April 13, 2026

Status Verified

April 1, 2026

Enrollment Period

3.2 years

First QC Date

November 18, 2025

Last Update Submit

April 9, 2026

Conditions

Keywords

Cardiovascular Autonomic Neuropathy (CAN)Acute Kidney Injury (AKI)Coronary Artery Bypass Graft (CABG)

Outcome Measures

Primary Outcomes (1)

  • Incidence of Acute Kidney Injury (AKI)

    AKI will be assessed according to KDIGO criteria using serum creatinine, BUN, GFR values, and urine output within the first 7 days postoperatively.

    Postoperative 7 days

Study Arms (1)

CABG Surgery Cohort

This cohort includes adult patients undergoing isolated coronary artery bypass graft (CABG) surgery with extracorporeal circulation (ECC). Each participant is evaluated preoperatively for cardiovascular autonomic neuropathy (CAN) using the Valsalva maneuver, sitting-to-standing test, and cold/heat test. Demographic, hemodynamic, and laboratory data, as well as regional cerebral oxygen saturation (rSO₂), are recorded. Postoperative outcomes include acute kidney injury (AKI) assessed by KDIGO criteria, complications, ICU and hospital stay, and mortality. No intervention is applied.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study includes adult patients (≥18 years old) scheduled for elective isolated Coronary Artery Bypass Graft (CABG) surgery with planned extracorporeal circulation (ECC). Participants will be evaluated preoperatively for cardiovascular autonomic neuropathy (CAN) using standardized tests. Patients with chronic kidney failure, severe chronic respiratory disease, uncontrolled hypertension, or conditions preventing autonomic testing are excluded. Both male and female adults are eligible, and all participants must provide informed consent.

You may qualify if:

  • Adults aged 18 years or older
  • Scheduled for elective isolated Coronary Artery Bypass Graft (CABG) surgery with planned extracorporeal circulation (ECC)
  • Provide informed consent

You may not qualify if:

  • Chronic kidney failure or dialysis
  • Severe chronic respiratory disease (COPD, asthma, chronic bronchitis) affecting test reliability
  • Uncontrolled hypertension
  • Use of antiarrhythmic drugs affecting heart rate-based autonomic tests
  • Orthopedic or neurological conditions preventing standing tests

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Akdeniz University, Faculty of Medicine, Department of Anesthesiology and Reanimation

Antalya, Antalya, 07050, Turkey (Türkiye)

Location

Related Links

MeSH Terms

Conditions

Acute Kidney Injury

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Anesthesiology, Akdeniz University, Antalya, Turkey

Study Record Dates

First Submitted

November 18, 2025

First Posted

November 28, 2025

Study Start

November 4, 2021

Primary Completion

January 10, 2025

Study Completion

March 10, 2025

Last Updated

April 13, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared. The data will be used solely for the purposes of this study."

Locations